Stock comparison
AbbVie
ABBV$381.1BHealthcare Market cap, Sector
Abbott Laboratories
ABT$152.25BHealthcare Market cap, Sector
AbbVie
ABBV 52 ABT
Based on the combined fit scores from all four strategies. The breakdown by strategy is below.
Fit scores by strategy
Side-by-side metrics
| Metric | ABBV | ABT |
|---|---|---|
| Market cap | Winner: $381.1B | $152.25B |
| P/E (TTM) | 103.6x | 23.5x Winner |
| EV/EBIT | 21.8x | 21.7x Winner |
| ROIC (TTM) |
Where each one wins
The metrics with the widest gap between the two, biggest differences first.
ABBV leads on
- Revenue CAGR 5y2.14%vs 0.72%+66%
- Market cap$381.1Bvs $152.25B+60%
- ROIC (TTM)10.29%vs 6.56%+36%
- Gross margin73.46%vs 56.38%+23%
ABT leads on
More like ABBV
More like ABT
Related on invest-like
For education only. Fit scores apply each investor's published criteria to public financial data. They are not personal recommendations.